LAMEA Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Antibody Therapeutics Market would witness market growth of 17.0 % CAGR during the forecast period (2023-2030).

Antibody-drug conjugates (ADCs) represent a burgeoning trend in targeted cancer therapy. ADCs combine the specificity of monoclonal antibodies with potent cytotoxic agents, allowing for precise delivery of chemotherapy to cancer cells while minimizing damage to healthy tissues. Developing novel ADCs with improved payload delivery and reduced toxicity is a focus of ongoing research. The trend towards personalized medicine is influencing antibody therapeutics development. Biomarker identification and patient stratification strategies are becoming integral in clinical trial design. Tailoring antibody therapies to specific patient subgroups based on biomarker profiles enhances treatment outcomes and minimizes unnecessary exposure to treatments with limited efficacy.

Integrating AI and machine learning in antibody discovery and development accelerates drug development. These methods enable quick analysis of massive datasets, prediction of antibody-antigen interactions, and lead candidate optimization. AI-driven approaches enhance the efficiency of antibody engineering, reducing development timelines and costs. Combinatorial approaches involving multiple antibodies or combining antibodies with other treatment modalities are gaining traction. Synergistic effects can be achieved by targeting different aspects of disease pathways. Combination therapies, such as combining checkpoint inhibitors with other immune modulators, are explored to enhance therapeutic responses. Exploring novel antibody formats beyond traditional monoclonal antibodies is a growing trend. Single-domain antibodies (nanobodies), antibody fragments, and multispecific antibodies are gaining attention for their unique properties, such as improved tissue penetration and rapid clearance. These formats open new possibilities for therapeutic innovation and more convenient administration routes.

The UAE's strategic focus on becoming a biotechnology hub has catalyzed the growth of the antibody therapeutics. It plays a crucial role in oncology, and expanding these treatments in the UAE contributes to advancements in cancer care. The UAE's biopharmaceutical industry is involved in the development of biosimilar antibodies. Expanding antibody therapeutics ensures that patients in the UAE have access to advanced and targeted therapies. The UAE's investment in biomanufacturing capabilities supports the local production of antibody therapeutics. Due to these aspects, the market will expand across the LAMEA region in upcoming years.

The Brazil market dominated the LAMEA Antibody Therapeutics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $12,158.1 million by 2030. The Argentina market is exhibiting a CAGR of 17.7% during (2023 - 2030). Additionally, The UAE market would experience a CAGR of 16.7% during (2023 - 2030).

Based on Route of Administration, the market is segmented into Intravenous, Subcutaneous, and Others. Based on Format, the market is segmented into, Monoclonal Antibody, Polyclonal Antibody Therapy, Bispecific Antibody, Antibody fragment & Others. Based on Source, the market is segmented into Human, Humanized, and Chimeric. Based on End User, the market is segmented into Hospitals, Long-term care facilities, and Others. Based on Disease Areas, the market is segmented into Autoimmune & Inflammatory Diseases, Neurology, Osteology, Hematology, Oncology, Infectious Diseases, Immunology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd, AbbVie, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Merck KGaA, Bristol Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Novartis AG, Biogen, Inc. and Amgen, Inc.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

Intravenous
Subcutaneous
Others

By Format

Monoclonal Antibody
Polyclonal Antibody Therapy
Bispecific Antibody
Antibody fragment & Others

By Source

Human
Humanized
Chimeric

By End User

Hospitals
Long-term care facilities
Other

By Disease Areas

Autoimmune & Inflammatory Diseases
Neurology
Osteology
Hematology
Oncology
Infectious Diseases
Immunology
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

F. Hoffmann-La Roche Ltd
AbbVie, Inc.
Johnson & Johnson (Johnson & Johnson Services, Inc.)
Merck KGaA
Bristol Myers Squibb Company
AstraZeneca PLC
Sanofi S.A.
Novartis AG
Biogen, Inc.
Amgen, Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization freeb

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Antibody Therapeutics Market, by Route of Administration
- 1.4.2 LAMEA Antibody Therapeutics Market, by Format
- 1.4.3 LAMEA Antibody Therapeutics Market, by Source
- 1.4.4 LAMEA Antibody Therapeutics Market, by End User
- 1.4.5 LAMEA Antibody Therapeutics Market, by Disease Areas
- 1.4.6 LAMEA Antibody Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Antibody Therapeutics market.

Chapter 5. LAMEA Antibody Therapeutics Market by Route of Administration

5.1 LAMEA Intravenous Market by Country
5.2 LAMEA Subcutaneous Market by Country
5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Antibody Therapeutics Market by Format

6.1 LAMEA Monoclonal Antibody Market by Country
6.2 LAMEA Polyclonal Antibody Therapy Market by Country
6.3 LAMEA Bispecific Antibody Market by Country
6.4 LAMEA Antibody fragment & Others Market by Country

Chapter 7. LAMEA Antibody Therapeutics Market by Source

7.1 LAMEA Human Market by Country
7.2 LAMEA Humanized Market by Country
7.3 LAMEA Chimeric Market by Country
7.4 LAMEA Others Market by Country

Chapter 8. LAMEA Antibody Therapeutics Market by End User

8.1 LAMEA Hospitals Market by Country
8.2 LAMEA Long-term care facilities Market by Country
8.3 LAMEA Others Market by Country

Chapter 9. LAMEA Antibody Therapeutics Market by Disease Areas

9.1 LAMEA Autoimmune & Inflammatory Diseases Market by Country
9.2 LAMEA Neurology Market by Country
9.3 LAMEA Osteology Market by Country
9.4 LAMEA Hematology Market by Country
9.5 LAMEA Oncology Market by Country
9.6 LAMEA Infectious Diseases Market by Country
9.7 LAMEA Immunology Market by Country
9.8 LAMEA Others Market by Country

Chapter 10. LAMEA Antibody Therapeutics Market by Country

10.1 Brazil Antibody Therapeutics Market
- 10.1.1 Brazil Antibody Therapeutics Market by Route of Administration
- 10.1.2 Brazil Antibody Therapeutics Market by Format
- 10.1.3 Brazil Antibody Therapeutics Market by Source
- 10.1.4 Brazil Antibody Therapeutics Market by End User
- 10.1.5 Brazil Antibody Therapeutics Market by Disease Areas
10.2 Argentina Antibody Therapeutics Market
- 10.2.1 Argentina Antibody Therapeutics Market by Route of Administration
- 10.2.2 Argentina Antibody Therapeutics Market by Format
- 10.2.3 Argentina Antibody Therapeutics Market by Source
- 10.2.4 Argentina Antibody Therapeutics Market by End User
- 10.2.5 Argentina Antibody Therapeutics Market by Disease Areas
10.3 UAE Antibody Therapeutics Market
- 10.3.1 UAE Antibody Therapeutics Market by Route of Administration
- 10.3.2 UAE Antibody Therapeutics Market by Format
- 10.3.3 UAE Antibody Therapeutics Market by Source
- 10.3.4 UAE Antibody Therapeutics Market by End User
- 10.3.5 UAE Antibody Therapeutics Market by Disease Areas
10.4 Saudi Arabia Antibody Therapeutics Market
- 10.4.1 Saudi Arabia Antibody Therapeutics Market by Route of Administration
- 10.4.2 Saudi Arabia Antibody Therapeutics Market by Format
- 10.4.3 Saudi Arabia Antibody Therapeutics Market by Source
- 10.4.4 Saudi Arabia Antibody Therapeutics Market by End User
- 10.4.5 Saudi Arabia Antibody Therapeutics Market by Disease Areas
10.5 South Africa Antibody Therapeutics Market
- 10.5.1 South Africa Antibody Therapeutics Market by Route of Administration
- 10.5.2 South Africa Antibody Therapeutics Market by Format
- 10.5.3 South Africa Antibody Therapeutics Market by Source
- 10.5.4 South Africa Antibody Therapeutics Market by End User
- 10.5.5 South Africa Antibody Therapeutics Market by Disease Areas
10.6 Nigeria Antibody Therapeutics Market
- 10.6.1 Nigeria Antibody Therapeutics Market by Route of Administration
- 10.6.2 Nigeria Antibody Therapeutics Market by Format
- 10.6.3 Nigeria Antibody Therapeutics Market by Source
- 10.6.4 Nigeria Antibody Therapeutics Market by End User
- 10.6.5 Nigeria Antibody Therapeutics Market by Disease Areas
10.7 Rest of LAMEA Antibody Therapeutics Market
- 10.7.1 Rest of LAMEA Antibody Therapeutics Market by Route of Administration
- 10.7.2 Rest of LAMEA Antibody Therapeutics Market by Format
- 10.7.3 Rest of LAMEA Antibody Therapeutics Market by Source
- 10.7.4 Rest of LAMEA Antibody Therapeutics Market by End User
- 10.7.5 Rest of LAMEA Antibody Therapeutics Market by Disease Areas

Chapter 11. Company Profiles

11.1 F. Hoffmann-La Roche Ltd.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Segmental and Regional Analysis
- 11.1.4 Research & Development Expense
- 11.1.5 Recent strategies and developments:
  - 11.1.5.1 Partnerships, Collaborations, and Agreements:
  - 11.1.5.2 Product Launches and Product Expansions:
- 11.1.6 SWOT Analysis
11.2 AbbVie, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expense
- 11.2.5 Recent strategies and developments:
  - 11.2.5.1 Partnerships, Collaborations, and Agreements:
  - 11.2.5.2 Acquisition and Mergers:
- 11.2.6 SWOT Analysis
11.3 Johnson & Johnson (Johnson & Johnson Services, Inc.)
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental &Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 Recent strategies and developments:
  - 11.3.5.1 Partnerships, Collaborations, and Agreements:
- 11.3.6 SWOT Analysis
11.4 Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Segmental and Regional Analysis
- 11.4.4 Research & Development Expense
- 11.4.5 Recent strategies and developments:
  - 11.4.5.1 Partnerships, Collaborations, and Agreements:
- 11.4.6 SWOT Analysis
11.5 Bristol Myers Squibb Company
- 11.5.1 Company Overview
- 11.5.2 Financial Analysis
- 11.5.3 Regional Analysis
- 11.5.4 Research & Development Expenses
- 11.5.5 Recent strategies and developments:
  - 11.5.5.1 Acquisition and Mergers:
- 11.5.6 SWOT Analysis
11.6 AstraZeneca PLC
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Research & Development Expenses
- 11.6.5 SWOT Analysis
11.7 Sanofi S.A.
- 11.7.1 Company Overview
- 11.7.2 Financial Analysis
- 11.7.3 Segmental and Regional Analysis
- 11.7.4 Research & Development Expense
- 11.7.5 SWOT Analysis
11.8 Novartis AG
- 11.8.1 Company Overview
- 11.8.2 Financial Analysis
- 11.8.3 Segmental and Regional Analysis
- 11.8.4 Research & Development Expense
- 11.8.5 SWOT Analysis
11.9 Biogen, Inc.
- 11.9.1 Company Overview
- 11.9.2 Financial Analysis
- 11.9.3 Regional Analysis
- 11.9.4 Research & Development Expense
- 11.9.5 SWOT Analysis
11.10. Amgen, Inc.
- 11.10.1 Company Overview
- 11.10.2 Financial Analysis
- 11.10.3 Regional Analysis
- 11.10.4 Research & Development Expenses
- 11.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 3 LAMEA Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 4 LAMEA Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 5 LAMEA Intravenous Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Intravenous Market by Country, 2023 - 2030, USD Million
TABLE 7 LAMEA Subcutaneous Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Subcutaneous Market by Country, 2023 - 2030, USD Million
TABLE 9 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 11 LAMEA Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 12 LAMEA Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 13 LAMEA Monoclonal Antibody Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Monoclonal Antibody Market by Country, 2023 - 2030, USD Million
TABLE 15 LAMEA Polyclonal Antibody Therapy Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Polyclonal Antibody Therapy Market by Country, 2023 - 2030, USD Million
TABLE 17 LAMEA Bispecific Antibody Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Bispecific Antibody Market by Country, 2023 - 2030, USD Million
TABLE 19 LAMEA Antibody fragment & Others Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Antibody fragment & Others Market by Country, 2023 - 2030, USD Million
TABLE 21 LAMEA Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 22 LAMEA Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 23 LAMEA Human Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Human Market by Country, 2023 - 2030, USD Million
TABLE 25 LAMEA Humanized Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Humanized Market by Country, 2023 - 2030, USD Million
TABLE 27 LAMEA Chimeric Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Chimeric Market by Country, 2023 - 2030, USD Million
TABLE 29 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 31 LAMEA Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 32 LAMEA Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 33 LAMEA Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 34 LAMEA Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 35 LAMEA Long-term care facilities Market by Country, 2019 - 2022, USD Million
TABLE 36 LAMEA Long-term care facilities Market by Country, 2023 - 2030, USD Million
TABLE 37 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 38 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 39 LAMEA Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 40 LAMEA Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 41 LAMEA Autoimmune & Inflammatory Diseases Market by Country, 2019 - 2022, USD Million
TABLE 42 LAMEA Autoimmune & Inflammatory Diseases Market by Country, 2023 - 2030, USD Million
TABLE 43 LAMEA Neurology Market by Country, 2019 - 2022, USD Million
TABLE 44 LAMEA Neurology Market by Country, 2023 - 2030, USD Million
TABLE 45 LAMEA Osteology Market by Country, 2019 - 2022, USD Million
TABLE 46 LAMEA Osteology Market by Country, 2023 - 2030, USD Million
TABLE 47 LAMEA Hematology Market by Country, 2019 - 2022, USD Million
TABLE 48 LAMEA Hematology Market by Country, 2023 - 2030, USD Million
TABLE 49 LAMEA Oncology Market by Country, 2019 - 2022, USD Million
TABLE 50 LAMEA Oncology Market by Country, 2023 - 2030, USD Million
TABLE 51 LAMEA Infectious Diseases Market by Country, 2019 - 2022, USD Million
TABLE 52 LAMEA Infectious Diseases Market by Country, 2023 - 2030, USD Million
TABLE 53 LAMEA Immunology Market by Country, 2019 - 2022, USD Million
TABLE 54 LAMEA Immunology Market by Country, 2023 - 2030, USD Million
TABLE 55 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 56 LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 57 LAMEA Antibody Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 58 LAMEA Antibody Therapeutics Market by Country, 2023 - 2030, USD Million
TABLE 59 Brazil Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 60 Brazil Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 61 Brazil Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 62 Brazil Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 63 Brazil Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 64 Brazil Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 65 Brazil Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 66 Brazil Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 67 Brazil Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 68 Brazil Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 69 Brazil Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 70 Brazil Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 71 Argentina Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 72 Argentina Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 73 Argentina Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 74 Argentina Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 75 Argentina Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 76 Argentina Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 77 Argentina Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 78 Argentina Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 79 Argentina Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 80 Argentina Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 81 Argentina Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 82 Argentina Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 83 UAE Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 84 UAE Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 85 UAE Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 UAE Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 UAE Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 88 UAE Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 89 UAE Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 90 UAE Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 91 UAE Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 92 UAE Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 93 UAE Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 94 UAE Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 95 Saudi Arabia Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 96 Saudi Arabia Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 97 Saudi Arabia Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 98 Saudi Arabia Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 99 Saudi Arabia Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 100 Saudi Arabia Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 101 Saudi Arabia Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 102 Saudi Arabia Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 103 Saudi Arabia Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 104 Saudi Arabia Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 105 Saudi Arabia Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 106 Saudi Arabia Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 107 South Africa Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 108 South Africa Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 109 South Africa Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 110 South Africa Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 111 South Africa Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 112 South Africa Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 113 South Africa Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 114 South Africa Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 115 South Africa Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 116 South Africa Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 117 South Africa Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 118 South Africa Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 119 Nigeria Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 120 Nigeria Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 121 Nigeria Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 122 Nigeria Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 123 Nigeria Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 124 Nigeria Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 125 Nigeria Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 126 Nigeria Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 127 Nigeria Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 128 Nigeria Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 129 Nigeria Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 130 Nigeria Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 131 Rest of LAMEA Antibody Therapeutics Market, 2019 - 2022, USD Million
TABLE 132 Rest of LAMEA Antibody Therapeutics Market, 2023 - 2030, USD Million
TABLE 133 Rest of LAMEA Antibody Therapeutics Market by Route of Administration, 2019 - 2022, USD Million
TABLE 134 Rest of LAMEA Antibody Therapeutics Market by Route of Administration, 2023 - 2030, USD Million
TABLE 135 Rest of LAMEA Antibody Therapeutics Market by Format, 2019 - 2022, USD Million
TABLE 136 Rest of LAMEA Antibody Therapeutics Market by Format, 2023 - 2030, USD Million
TABLE 137 Rest of LAMEA Antibody Therapeutics Market by Source, 2019 - 2022, USD Million
TABLE 138 Rest of LAMEA Antibody Therapeutics Market by Source, 2023 - 2030, USD Million
TABLE 139 Rest of LAMEA Antibody Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 140 Rest of LAMEA Antibody Therapeutics Market by End User, 2023 - 2030, USD Million
TABLE 141 Rest of LAMEA Antibody Therapeutics Market by Disease Areas, 2019 - 2022, USD Million
TABLE 142 Rest of LAMEA Antibody Therapeutics Market by Disease Areas, 2023 - 2030, USD Million
TABLE 143 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 144 Key information - AbbVie, Inc.
TABLE 145 Key Information - Johnson & Johnson
TABLE 146 key Information - Merck KGaA
TABLE 147 Key Information - Bristol Myers Squibb Company
TABLE 148 KEY INFORMATION - AstraZeneca PLC
TABLE 149 Key Information - Sanofi S.A.
TABLE 150 Key Information - Novartis AG
TABLE 151 Key Information - Biogen, Inc.
TABLE 152 Key Information - Amgen, Inc.

LAMEA Antibody Therapeutics Market Size, Share & Trends Analysis Report By Route of Administration (Intravenous, Subcutaneous, and Others), By Format, By Source, By End User, By Disease Areas, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents